Mr. Bryan Baldasare

Insider Reports History

Location
Cincinnati, OH
Signature
/s/ Eric A Adams, attorney-in-fact for Mr. Bryan Baldasare
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mr. Bryan Baldasare:

Form 4 holding Exec VP & CFO

MERIDIAN BIOSCIENCE INC

Security class
Common Stock
Shares / value
60,929
Estimated value
$1,241,733
Report date
15 Dec 2021
Price
$20.38
Ownership
Direct
Form 4 holding Director

InMed Pharmaceuticals Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
8,500
Estimated value
Report date
23 Dec 2023
Price
Ownership
Direct
Underlying class
Common shares
Underlying amount
Form 4 holding Director

InMed Pharmaceuticals Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
975
Estimated value
Report date
20 Dec 2024
Price
Ownership
Direct
Underlying class
Common shares
Underlying amount

Insider Reports Filed by Mr. Bryan Baldasare

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .